4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0001140361-23-000721
President and CEO sold 30,000 shares at an average $19.20 ($575,892)
- President and CEO acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Coulie Bernard · President and CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-03 | Exercise or conversion : show line 1 in the form | +15,000 | $2.08 | $31,200 | 108,812 | D |
| 2023-01-03 | Sale : show line 2 in the form | −15,000 | $19.33 | $289,952 | 93,812 | D |
| 2023-01-04 | Exercise or conversion : show line 3 in the form | +15,000 | $2.08 | $31,200 | 108,812 | D |
| 2023-01-04 | Sale : show line 4 in the form | −15,000 | $19.06 | $285,941 | 93,812 | D |
| Open-market sales · 30,000 sh · avg $19.20 · $575,892 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-01-03 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −15,000 | 282,380 | D |
| 2023-01-04 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −15,000 | 267,380 | D |
Loading xslF345X03/form4.xml…